920 results on '"Cohen, Mauricio G."'
Search Results
102. Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: A 10-years us perspective
103. Association between anti-human heat shock protein-60 and interleukin-2 with coronary artery calcium score
104. Antiplatelet therapies and the role of antiplatelet resistance in acute coronary syndrome
105. The paradoxical use of cardiac catheterization in patients with non–ST-elevation acute coronary syndromes: Lessons from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC /AHA Guidelines (CRUSADE) Quality Improvement Initiative
106. Health-related quality of life 1-3 years post-myocardial infarction: its impact on prognosis
107. Aortic balloon valvuloplasty and severe systolic dysfunction. Is there a danger zone?
108. Transradial Access for High-Risk Percutaneous Coronary Intervention: Implications of the Risk-Treatment Paradox
109. Future Perspectives of Left Main Revascularization Trials
110. Diabetes association with self-reported health, resource utilization, and prognosis post-myocardial infarction
111. Clinical outcomes with on-label and off-label use of the transcatheter heart valve in the United States
112. Impact of CMS coverage decision on access to transcatheter aortic valve replacement
113. Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: Insights from the PROTECT II study
114. Successful transradial retrieval of an embolized guidewire during transradial vascular access
115. The association between body mass index and coronary artery disease severity: A comparison of black and white patients
116. Reversal of end stage renal disease in patient with transcatheter aortic valve replacement
117. Safety of transradial cardiac catheterization in patients with end-stage liver disease
118. The Use of Vascular Closure Devices and Impact on Major Bleeding and Net Adverse Clinical Events (NACEs) in Balloon Aortic Valvuloplasty: A Sub-Analysis of the BRAVO Study
119. Fourth universal definition of myocardial infarction (2018)
120. Health-related quality of life 1–3 years post-myocardial infarction: its impact on prognosis
121. Transseptal antegrade transcatheter aortic valve replacement for patients with no other access approach—A contemporary experience
122. Considerations for cardiac catheterization laboratory procedures during the COVID-19 pandemic perspectives from the Society for Cardiovascular Angiography and Interventions Emerging Leader Mentorship (SCAI ELM) Members and Graduates
123. TAVR in Low-Population Density Areas: Assessing Healthcare Access for Older Adults with Severe Aortic Stenosis
124. Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry
125. Measuring and Treating Serum Lipids in Patients in a Chest Pain Observation Unit
126. Racial Differences Among High-Risk Patients Presenting With Non–ST-Segment Elevation Acute Coronary Syndromes (Results from the SYNERGY Trial)
127. Clinical characteristics, process of care, and outcomes of Hispanic patients presenting with nonuST-segment elevation acute coronary syndromes: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE)
128. New-onset versus prior history of atrial fibrillation: Outcomes from the AFFIRM trial
129. A simple prediction rule for significant renal artery stenosis in patients undergoing cardiac catheterization
130. Meta-analysis of PCI vs. CABG for left main disease revisited
131. Balloon Mitral Valvuloplasty in the United States: A 13-Year Perspective
132. Cerebral Protection against Left Ventricular Thrombus during Transcatheter Aortic Valve Replacement in a Patient with Critical Aortic Stenosis
133. A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial
134. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: Management of paravalvular regurgitation after TAVR
135. Non-pharmacologic stroke prevention in atrial fibrillation: An issue without closure
136. A-072 Title: Comparison of Aortic Regurgitation Index to Aortic Angiogram and Echocardiography for the Assessment of Aortic Regurgitation after Edwards-Sapien Transcatheter Valve
137. A-054 Title: Trends and Predictors of Length of Stay after Balloon Aortic Valvuloplasty in United States: A 12 year perspective
138. A-036 Title: Complications of Balloon Mitral Valvuloplasty in the United States: A 12 year perspective
139. B-040 Title: Influence of Comorbidities on Mortality in Patients Undergoing Percutaneous Coronary Intervention
140. Therapeutic Goals in Patients with Refractory Angina
141. Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction
142. Clinical characteristics, process of care, and outcomes of Hispanic patients presenting with non–ST-segment elevation acute coronary syndromes: Results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE)
143. Has the gender gap in percutaneous coronary intervention-related mortality narrowed?
144. Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction
145. Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America: results from the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial
146. A Tale of Two Pressures: A Case of Pseudo-Prosthetic Mitral Valve Stenosis
147. The Kinetics of Integrilin Limited by Obesity: A multicenter randomized pharmacokinetic and pharmacodynamic clinical trial
148. Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy
149. Percutaneous left ventricular assist devices—Still waiting for the final word
150. Arterial Pressure Recovery After Balloon Aortic Valvuloplasty with Impella LV support: E-043
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.